Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-190631
Filing Date
2023-07-21
Accepted
2023-07-20 19:52:58
Documents
1
Group Members
CURTIS HUFFFREEBIRD INVESTMENTS LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d531369dsc13ga.htm SC 13G/A 68119
  Complete submission text file 0001193125-23-190631.txt   70020
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Subject) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42217 | Film No.: 231100821
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2800 POST OAK BLVD. SUITE 2000 HOUSTON TX 77056
Business Address 2800 POST OAK BLVD. SUITE 2000 HOUSTON TX 77056 713-961-0118
Freebird Partners LP (Filed by) CIK: 0001955231 (see all company filings)

EIN.: 331028238 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G/A